Dec 31, 2025
Micron Stock Cools Off After Massive Surge In 2025

Micron Technology Inc (NASDAQ:MU) shares are trading slightly lower Wednesday morning as investors take profits following a blistering year-to-date rally of roughly 230%. Here’s what investors need to know. Micron Technology shares are experiencing downward pressure. What’s driving MU stock…

Dec 31, 2025
Taiwan Semiconductor Starts Making Its Most Powerful Chips At Scale

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) stock rose on Wednesday after the company confirmed that it has officially begun volume production of its 2-nanometer chips. The contract chipmaker began mass production in the fourth quarter of 2025 at Fab 22 in…

Dec 31, 2025
TransDigm Agrees To Buy Stellant Systems For $960 Million

TransDigm Group Incorporated (NYSE:TDG) announced that it has reached an agreement to acquire Stellant Systems, Inc. in an all-cash transaction valued at approximately $960 million, further expanding its defense electronics portfolio. The deal, reported Wednesday, includes certain tax benefits and reflects…

Dec 31, 2025
Wedbush Downgrades Tower Semiconductor Stock To Neutral, Shares Slide

Shares of Tower Semiconductor Ltd.(NASDAQ:TSEM) are trading lower Wednesday after analysts at Wedbush downgraded their rating of the stock. Tower Semiconductor shares are under pressure. Why is TSEM stock retreating? Wedbush Downgrades Tower Semi Wedbush downgraded Tower Semiconductor from an outperform…

Dec 31, 2025
What’s Going On With Royalty Pharma Stock Wednesday?

Royalty Pharma plc (NASDAQ:RPRX) stock has gained around 53% year to date, as per data from Benzinga Pro. On Monday, Royalty Pharma acquired the final portion of PTC Therapeutics Inc.’s (NASDAQ:PTCT) remaining royalty on Roche Holdings AG’s (OTC:RHHBY) Evrysdi for…

Dec 31, 2025
FDA Fast-Tracks Axsome’s Alzheimer’s Agitation Drug, Stock Soars

On Wednesday, the U.S. Food and Drug Administration (FDA) accepted Axsome Therapeutics Inc.’s (NASDAQ:AXSM) supplemental New Drug Application (NDA) for AXS-05 (dextromethorphan HBr and bupropion HCl) for Alzheimer’s disease agitation. The FDA granted the application Priority Review designation and set…